Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors
Incyte Corporation
Incyte Corporation
Ascentage Pharma Group Inc.
Xencor, Inc.
Eli Lilly and Company
Cellerant Therapeutics
Synta Pharmaceuticals Corp.
INSYS Therapeutics Inc
Millennium Pharmaceuticals, Inc.
Daiichi Sankyo
Bristol-Myers Squibb